Filobasidium chernovii (Fonseca et al.) Liu et al.
商品貨號
B176989
Strain Designations
MF 1114/07 [CBS 11700]
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Comments
Clinical isolate
Resistant to caspofungin,anidulafungin,5-flucytosine and itroconazole.
Susceptible to amphotericin-B, posaconazole and voriconazole.
Morphology
On YM medium colonies are cream colored with a smooth, mucoid texture; the margin is entire. Cells are globose to ovoidal and single, in pairs and often in small clusters or short chains.? Elongate cells may be present. Small amount of sediment is formed.
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
ATCC® Medium 200: YM agar or YM broth
ATCC® Medium 25: Yeast extract-glucose medium
Human nasal swab culture, Cancer hospital, Kuwait; April, 2007.
Cross References
Nucleotide (GenBank) :
JQ070135
D1/D2 region of 28S rRNA gene
Nucleotide (GenBank) :
JQ070109
ITS including 5.8S rRNA gene
References
Khan Z, et al. Isolation of Cryptococcus magnus and Cryptococcus chernovii from nasal cavities of pediatric patients with acute lymphoblastic leukemia. Med. Mycol. 49(4): 439-443, 2011. PubMed: 20979444
